Codexis, Inc. (CDXS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Alison Moore Ph.D.
|
President, CEO & Director | 1M | -- | 1967 |
|
Ms. Georgia L. Erbez
|
CFO & Chief Business Officer | 745.96k | -- | 1967 |
|
Dr. Stefan Lutz Ph.D.
|
Chief Scientific Officer | 729.16k | -- | -- |
|
Mr. Britton Jimenez
|
Senior Vice President of Sales & Marketing | -- | -- | -- |
|
Ms. Karen Frechou-Armijo
|
Senior VP & Head of Human Resources | -- | -- | -- |
|
Mr. John Schiffhauer
|
Senior Vice President of Intellectual Property | -- | -- | -- |
Codexis, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 146
Description
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Corporate Governance
Upcoming Events
November 12, 2026 at 9:00 PM UTC
Codexis, Inc. Earnings Date
